The influence of various mucoadhesive polymers on in vitro performance of the resulting artificial saliva pump spray formulations

Iranian Journal of Pharmaceutical Research

Volumn 8, Issue 1, 2009, Pages 3-13

  Mehravaran, Nooshin ^a   Moghimi, Hamidreza ^a   Mortazavi, Seyed Alireza ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Artificial saliva; Carbomers; Cellulose derivatives; Mucoadhesion; Pump spray system; Rheology

Indexed keywords

CARBOMER; CARBOPOL 940; CARBOPOL 971; CARBOPOL 974P; CARBOXYMETHYLCELLULOSE; CELLULOSE DERIVATIVE; HYDROXYETHYLCELLULOSE; HYDROXYPROPYLMETHYLCELLULOSE; MAGNESIUM CHLORIDE; POLYMER; POTASSIUM CHLORIDE; POTASSIUM DIHYDROGEN PHOSPHATE; SALIVA SUBSTITUTE; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ADULT; AEROSOL; AGED; ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; FEMALE; FLOW KINETICS; HUMAN; HUMAN EXPERIMENT; MALE; MOLECULAR STABILITY; MUCOADHESION; NORMAL HUMAN; ODOR; ORGANOLEPTIC PROPERTY; PARTICLE SIZE; PH MEASUREMENT; PUMP DESIGN; PUMP SPRAY FORMULATION; SALIVA; SHEAR RATE; SHEAR STRESS; TASTE; THERMOSTABILITY; VISCOSITY;

EID: 67649094353     PISSN: 17350328     EISSN: 17266890     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Edgar WM and O'Mullane DM. Saliva and Oral Health. 2nd ed. British Dental Association, London (1996) 52-63
2. Robinson LB and Joseph R. preclinical Assessment of oral mucosal drug delivery systems. In: Bing L and Robinson R. (eds.) Drug Delivery to the Oral Cavity, Drugs and the Pharmaceutical Science. 2nd ed. Toylor & Francis, New York (2005) 78-135
3. Guyton AC and Hall JE. Textbook of Medical Physiology. 10th Ed., WB Saunders, pennsylvania (2000) 815-19
4. Sjögren's Syndrome Overview. (2004). Available from: http://mayoclinic.com
5. Dry Mouth. (2007). Available from: http://jada.Ada.org
6. Dry Mouth Treatment. (2006). Available from: www.clevelandclinic.org/ health
7. Davies AN, Daniels C, pugh R and Sharma K. A comparison of artificial saliva and pilocarpine in the management of xerostomia in patients with advanced cancer. Palliat. Med. (1999) 13: 81-83
8. Morrow, Robert M, Kuebker, McGinity, James W. Oral lubricant for athletic mouth protector., United States patent No: 4,537,689 (1985)
9. Shibasaki KI, Hiroshi O and Shouichi H. Artificial Saliva Composition. United States patent, no. 4,879,281 (1989)
10. Turgeon JA. Saliva Substitute. United States patent, no. 5,541,165 (1996)
11. Cilurzo F, Selmin F, Minghett p, Gennar S, Demartin F and Montanar L. Characterization and physical stability of fast-dissolving microparticles containing nifedipine. Eur. J. Pharm. Biopharm. (2008) 68: 579-588
12. Chayed S and Winnik FM. In vitro evaluation of the mucoadhesive properties of polysaccharide-based nanoparticulate oral drug delivery systems. Eur. J. Pharm. Biopharm. (2007) 65: 363-370
13. Grabovac V, Guggi D and Bernkop-Schnürch A. Comparison of the mucoadhesive properties of various polymers. Adv. Drug Del. Rev. (2005) 57: 1713-23
14. Bernkop-Schnürch A. Mucoadhesive systems in oral drug delivery. Drug Discovery Today (2005) 2: 83-87
15. Amerogen VN, Arie G and Veerman A. Therapeutic Composition for Replacing and/or Supplementing Body Fluids. United States patent, no. pCT/NL95/ 00046 (1995)
16. Fefelova NA, Nurkeeva ZS, Mun Grigoriy A and Vitaliy V. Mucoadhesive interactions of amphiphilic cationic copolymers based on (2-(methacryloyloxy) ethyl)trimethylammonium chloride. Eur. J. Pharm. Biopharm. (2007) 339: 25-32
17. Mortazavi SA and Smart JD. An in-vitro method for assessing the duration of mucoadhesion. J. Control. Rel. (1994) 31: 207-212
18. Mortazavi SA. A comparative study between the strength and duration of mucosa-adhesion of transbuccal carbomer based aqueous gels. Iranian J. Pharm. Res. (2002) 1: 7-13
19. Martin A, Bustamante p and Chun AHC. Physical Pharmacy. 4th Ed., Lea and Febiger, philadelphia (1993) 453-76